Top Small-cap Stock Picks From Morgan Stanley Following the Group's Upgrade to Neutral
Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings?
Viking Stock Rises 29% in Three Months: Time to Buy, Hold or Sell?
Earnings Preview: VKTX to Report Financial Results Post-market on October 23
$Viking Therapeutics(VKTX.US)$ is scheduled to release its financial results post-market on October 23 ET. Earnings PreviewAnalysts estimate $Viking Therapeutics(VKTX.US)$ to post revenue of USD0
Consumer, Labor Groups Urge FTC to Block Catalent Sale to Novo Nordisk - Report
Oppenheimer Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $138
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know
Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Where Will Viking Therapeutics Be in 5 Years?
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics Vs. Summit Therapeutics
With 74% Institutional Ownership, Viking Therapeutics, Inc. (NASDAQ:VKTX) Is a Favorite Amongst the Big Guns
Here's Why Viking Therapeutics, Inc. (VKTX) Fell More Than Broader Market
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
Maxim Group Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $120
Truist Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $90 to $125
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF) and Viking Therapeutics (VKTX)
Buy Rating Affirmed for Viking Therapeutics on Promising VK0214 and VK2735 Clinical Data